Indoor Harvest Corp (INQD)
0.0007
0.00 (0.00%)
USD |
OTCM |
May 03, 11:32
Indoor Harvest Enterprise Value: 2.335M for May 2, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 02, 2024 | 2.335M |
May 01, 2024 | 2.618M |
April 30, 2024 | 2.618M |
April 29, 2024 | 1.769M |
April 26, 2024 | 1.769M |
April 25, 2024 | 1.769M |
April 24, 2024 | 1.910M |
April 23, 2024 | 2.052M |
April 22, 2024 | 1.486M |
April 19, 2024 | 1.769M |
April 18, 2024 | 1.769M |
April 17, 2024 | 1.910M |
April 16, 2024 | 1.769M |
April 15, 2024 | 1.769M |
April 12, 2024 | 2.052M |
April 11, 2024 | 1.769M |
April 10, 2024 | 1.769M |
April 09, 2024 | 1.769M |
April 08, 2024 | 1.599M |
April 05, 2024 | 1.486M |
April 04, 2024 | 1.655M |
April 03, 2024 | 1.486M |
April 02, 2024 | 2.052M |
April 01, 2024 | 1.769M |
March 28, 2024 | 2.052M |
Date | Value |
---|---|
March 27, 2024 | 2.618M |
March 26, 2024 | 2.618M |
March 25, 2024 | 2.335M |
March 22, 2024 | 2.052M |
March 21, 2024 | 2.335M |
March 20, 2024 | 2.052M |
March 19, 2024 | 2.052M |
March 18, 2024 | 2.052M |
March 15, 2024 | 2.052M |
March 14, 2024 | 2.194M |
March 13, 2024 | 2.194M |
March 12, 2024 | 2.335M |
March 11, 2024 | 2.618M |
March 08, 2024 | 2.618M |
March 07, 2024 | 2.901M |
March 06, 2024 | 2.901M |
March 05, 2024 | 2.760M |
March 04, 2024 | 2.618M |
March 01, 2024 | 2.618M |
February 29, 2024 | 2.901M |
February 28, 2024 | 2.760M |
February 27, 2024 | 2.618M |
February 26, 2024 | 2.901M |
February 23, 2024 | 3.326M |
February 22, 2024 | 3.468M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
0.9557M
Minimum
May 11 2020
81.54M
Maximum
Feb 10 2021
13.30M
Average
8.087M
Median
Aug 22 2023
Enterprise Value Benchmarks
NovaBay Pharmaceuticals Inc | 2.666M |
Palatin Technologies Inc | 23.59M |
iBio Inc | 16.94M |
Theriva Biologics Inc | -13.05M |
Oragenics Inc | 3.127M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -0.3717M |
Total Expenses (Quarterly) | 0.2585M |
EPS Diluted (Quarterly) | -0.0001 |
Earnings Yield | -79.57% |
Normalized Earnings Yield | -91.29 |